Background: Benign enlargement of prostate (BEP) needs treatment based on evaluation of symptom scoring among which International prostate symptom score (IPSS) is the standard one but carries difficulty in completion of the form. A visual prostate symptom score (VPSS) can evaluate the symptom with similar efficacy in a larger population with lower education. Aim of the study: The study was aimed to evaluate the correlation of the VPSS with uroflowmetry parameters. Materials and Methods. Men provisionally diagnosed as BEP were requested to complete the IPSS and VPSS, consisting of pictograms to evaluate urinary frequency, nocturia, force of the stream and quality of life. The maximum (Qmax) and average urinary flow rate (Qave), voided volume (VV) and post-void residual (PVR) urine volumes were measured. Statistical analysis was performed using the chi square test and Spearman's tests. Results. The study included 45 men (mean age 66 years, range 50-78 yrs.), with median prostate weight of 40 gm. One fourth of the patients were illiterate. Majority of the patients could complete VPSS without physician's assistance (46%). With mean voided volume of 273 ml, mean Qmax and Qave were 10.8 and 5.7, respectively. There was significant negative correlation of VPSS with Qmax (r=-0.435, p=0.003) and negative correlation of IPSS with Qmax, though insignificant (r=-0
INTRODUCTION
The prevalence of lower urinary tract symptoms (LUTS) due to benign enlargement of prostate (BEP) in elderly population is 1 as high as 90% by age 85 . It includes voiding and storage LUTS and its impact on quality of life is highly variable. It is the patient's perception of severity that determines the choice of 2, 3 therapy . The pressure-flow study (PFS) is the reference standard for evaluating bladder outlet obstruction (BOO) due 4 to BEP . However, it is invasive and not practical in all patients. The international prostate symptom score (IPSS) is the standard questionnaire applied internationally, which can convert subjective symptoms into objective scores. It helps in formulating treatment plan by categorizing the patients into 5, 6 different severity groups .
The IPSS was meant to be a self administered tool to be used even in primary care setting. However, large proportion of patients found it difficult to comprehend especially by those 7 with lower educational level . As a result, many scoring systems have been developed but not satisfactorily applied.
Visual prostate symptom score (VPSS) is a pictogram based scoring system aimed to address difficulties encountered [8] [9] [10] with IPSS and uroflowmetry parameters .
We aimed to evaluate the correlation between the VPSS and IPSS and non-invasive uroflowmetry parameters in men with benign enlargement of prostate.
MATERIALS AND METHODS
This was a prospective study done at Nepalgunj Medical College, a tertiary care center in Mid Western part of Nepal. Patients presenting with LUTS who were provisionally diagnosed as BEP were enrolled. A total of 45 patients were included over a period of ten months from November 2014 to August 2015.
After full medical history was obtained, digital rectal examination, urine analysis, serum prostate-specific antigen (PSA) and creatinine measurement, and ultrasonography were performed to evaluate the urinary system. Ultrasonography (USG) was also used for residual urine measurement. The peak urinary flow rate (Qmax), average urinary flow rate (Qave), and voided volume were measured using a Nidhi flow Uroflowmeter, 814. Patients were requested to complete the Nepali version of IPSS questionnaire, which consists of 7 questions: Q1, incomplete emptying; Q2, frequency; Q3, intermittency; Q4, urgency; Q5, weak stream; Q6, straining; and Q7, nocturia including additional question on quality of life (QoL). The patients were also requested to complete the VPSS questionnaire. The VPSS consists of 4 pictograms to evaluate the following domains: Q1, force of urinary stream; Q2, frequency; Q3, nocturia, and Q4, QoL of patients.
The chi-square test was used for contingency table analysis to evaluate factors associated with how the respondent completed the IPSS and VPSS questionnaires. Spearman's test was used for correlation analysis between the IPSS and the VPSS and the uroflowmetry parameters. A two-tailed P-value <0.05 was accepted as statistically significant.
RESULTS
Mean age of the patients was 66±7.07 years with a range of 50 to 78 years. Most of them were in their 60s (44%). Median prostatic weight was 40 gm. as determined by ultrasonography. Median duration of LUTS was 15 months (range 4-60 months). Other characteristics are as described in Table I .
Number of patients who were literate was 30 with median grade of schooling of eighth standard (Figure 2 ). Farmers were the main patient group (53%). 
Figure 2: Educational status of the patients
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Frequency Overall the patients who could complete VPSS alone without anyone's assistance was 46%. Medical personnel had to assist in 24% of the cases. On the other hand, 75% of the cases required the assistance of a doctor while completing IPSS (Table II) . 
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DISCUSSION
While the IPSS is the internationally recognized standard tool for assessment of patients with BEP, lower education level of the patients hinders their appropriate assessment and [11] [12] [13] treatment . Newly devised VPSS aims to address the difficulties associated with the use of IPSS and has greatly 8, 9, 14, 15 succeeded in that . In current study, mean IPSS and VPSS were 23 and 11.84, respectively. Higher score of IPSS denotes severe symptoms which more often requires operative In present study, VPSS shows negative as well as significant correlation with Qmax and Qave. The results are similar with 8, 9 the studies by van der Walt and Wessels SG . There is positive correlation between specific questions of IPSS related to frequency, nocturia and weak stream and the respective components of VPSS.
CONCLUSION
The VPSS is equivalent to the IPSS in terms of correlation with uroflowmetry parameters and can therefore be used instead of the IPSS to evaluate LUTS in men with benign enlargement of prostate.
